FBL8 Antibodies

Santa Cruz Biotechnology offers a broad range of FBL8 monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBL8 plays a critical role in ribosome biogenesis and cellular proliferation. Understanding FBL8 function is vital, as it influences various cellular processes and has potential links to diseases related to cell growth and differentiation. Research has shown that FBL8 is expressed in multiple tissue types and can be detected at different stages of cell development. Advanced detection methods allow researchers to track FBL8 localization and expression patterns with high specificity. Multiple validation studies have confirmed the reliability of detecting FBL8 across different experimental conditions. Ongoing studies continue to reveal new insights about FBL8's role in cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies for FBL8 enable researchers worldwide to advance scientific understanding of cellular biology and disease mechanisms.